Exercise, Pulmonary and Quality of Life

Skeletal Muscle Pathology in Pulmonary Arterial Hypertension and Its Contribution to Exercise Intolerance

Journal of the American Heart Association

FEBRUARY 8, 2025

Pulmonary arterial hypertension is a disease of the pulmonary vasculature, resulting in elevated pressure in the pulmonary arteries and disrupting the physiological coordination between the right heart and the pulmonary circulation. Journal of the American Heart Association, Ahead of Print.

Exercise

Exercise Pulmonary Hypertension Quality of Life

Cardiopulmonary Exercise Test Interpretation Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association

Journal of the American Heart Association

JANUARY 9, 2025

Because these patients are living longer, treatment and disease surveillance targets have shifted toward enhancing quality of life and functional status. The purpose of this statement is to provide a lifespan approach to the interpretation of cardiopulmonary exercise testing in patients with congenital heart disease.

Congenital Heart Disease

Congenital Heart Disease Congenital Exercise Heart Disease

Feasibility of postoperative home-based pulmonary function training for lung cancer patients: a real-world study

Journal of Cardiothoracic Surgery

APRIL 3, 2025

Pulmonary surgery can significantly impact patients respiratory function and reduce their quality of life. Previous studies have shown that perioperative breathing exercises (BE) can facilitate the recovery o.

Pulmonary

Pulmonary Quality of Life Cancer Exercise

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Efficacy and safety of step-by-step Baduanjin exercise based on doctor-nurse-patient integration mode for pulmonary rehabilitation in patients after lobectomy due to pulmonary tuberculosis: a randomized controlled clinical trial

Journal of Cardiothoracic Surgery

SEPTEMBER 8, 2024

Some pulmonary tuberculosis patients may require lung resection surgery. Postoperative pulmonary rehabilitation is essential to restore the lung function and maintain quality of life. We aimed to study the pul.

Pulmonary

Pulmonary Quality of Life Nursing Exercise

Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data

DAIC

APRIL 22, 2024

RELIEVE-HF failed to meet its primary efficacy endpoint and did not reduce heart failure events or improve quality of life in heart failure patients with a preserved ejection fraction (HFpEF). For more information: www.corviamedical.com If you enjoy this content, please share it with a colleague

Preserved Ejection Fraction

Preserved Ejection Fraction Quality of Life Heart Failure Pacemaker

Exercise Training in Patients With Hypertrophic Cardiomyopathy Without Left Ventricular Outflow Tract Obstruction: A Randomized Clinical Trial

Circulation

NOVEMBER 8, 2024

BACKGROUND:Patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction commonly experience reduced exercise capacity. Physical training improves exercise capacity in these patients, but whether the underlying effects of exercise are a result of central hemodynamic or peripheral improvement is unclear.

Exercise

Exercise Cardiomyopathy Quality of Life Pulmonary

Bayer to Present New Investigational Heart Failure Data, Continued Portfolio Research in Chronic Kidney Disease at ACC.25

DAIC

MARCH 25, 2025

Efficacy of finerenone according to left atrial size in patients with heart failure and mildly reduced or preserved ejection fraction: An analysis of the FINEARTS-HF trial during the session " Finerenone: A Promising Addition to the Armamentarium or Merely an Academic Exercise?"

Preserved Ejection Fraction

Preserved Ejection Fraction Heart Failure Kidney Disease Research

Patient Enrollment Commenced in Pivotal Phase 3 Trial of CardiAMP Cell Therapy for the Treatment of Ischemic Heart Failure

DAIC

JULY 25, 2024

BioCardia previously confirmed alignment with the United States Food and Drug Administration (FDA) on the design of the 250-patient randomized, controlled trial and the minimum of 12-month primary composite endpoint of all cause death, reduction in major adverse cardiovascular events, and improvement in quality of life.

Heart Failure

Heart Failure Quality of Life CMS Reimbursement

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies

DAIC

MAY 16, 2024

This plaque narrows the blood vessels and reduces blood flow to the legs and feet, which may significantly impair physical function, walking performance and quality of life. Multiple studies have shown that these programs improve functional status, walking performance and quality of life compared to usual care.

Peripheral Arterial Disease

Peripheral Arterial Disease Exercise Ischemia Quality of Life

BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes

DAIC

MAY 2, 2024

a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the primary endpoint results of the open label roll-in cohort of the CardiAMP Cell Therapy in Chronic Myocardial Ischemia Trial. Getty Images milla1cf Thu, 05/02/2024 - 10:12 May 2, 2024 — BioCardia, Inc. ,

Ischemia

Ischemia Angina Heart Failure Outcomes

Bayer to Present New Investigational Heart Failure Data, Continued Portfolio Research

DAIC

MARCH 25, 2025

Efficacy of finerenone according to left atrial size in patients with heart failure and mildly reduced or preserved ejection fraction: An analysis of the FINEARTS-HF trial during the session " Finerenone: A Promising Addition to the Armamentarium or Merely an Academic Exercise?"

Preserved Ejection Fraction

Preserved Ejection Fraction Heart Failure Research Academic

Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP?HF II trial

European Journal of Heart Failure

DECEMBER 7, 2023

Patients with more severe obesity were more likely to have responder characteristics for atrial shunt therapy (fewer pacemakers and lower exercise pulmonary vascular resistance [PVR]). Pulmonary vascular resistance at rest and exercise decreased with higher BMI. Overall, 60.9% of patients had BMI ≥30 kg/m 2.

Preserved Ejection Fraction

Preserved Ejection Fraction Obesity Heart Failure BMI

Leaky Heart Valves

Dr. Sanjay Gupta

APRIL 4, 2022

We are blessed with 4 heart valves – 2 on the left side which are known as the mitral and aortic valves and 2 on the right side – the tricuspid and pulmonary valves. He is intolerant of exercise for the same reason. He swells up with swelling of the legs and the abdomen because of all this volume overload.

Heart Valves

Heart Valves Aortic valve Exercise Quality of Life

Dapagliflozin effects on exercise, cardiac remodeling, biomarkers, and renal and pulmonary function in heart failure patients: not as good as expected?

Frontiers in Cardiovascular Medicine

MARCH 17, 2025

mL/kg/min; p=0.297], while exercise ventilatory efficiency (VE/VCO2 slope) improved [from 34.2 NT-proBNP, ST-2, and hs-TNI did not change as overall body fluids and quality of life assessed by KCCQ. ResultsNone of the patients interrupted SGLT2-i for adverse events albeit follow-up was completed by 67 of 75 enrolled patients.

Exercise

Exercise Biomarkers Heart Failure Pulmonary

Cardiovascular Update

Skeletal Muscle Pathology in Pulmonary Arterial Hypertension and Its Contribution to Exercise Intolerance

Cardiopulmonary Exercise Test Interpretation Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association

Feasibility of postoperative home-based pulmonary function training for lung cancer patients: a real-world study

Webinars

Efficacy and safety of step-by-step Baduanjin exercise based on doctor-nurse-patient integration mode for pulmonary rehabilitation in patients after lobectomy due to pulmonary tuberculosis: a randomized controlled clinical trial

Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data

Exercise Training in Patients With Hypertrophic Cardiomyopathy Without Left Ventricular Outflow Tract Obstruction: A Randomized Clinical Trial

Bayer to Present New Investigational Heart Failure Data, Continued Portfolio Research in Chronic Kidney Disease at ACC.25

Patient Enrollment Commenced in Pivotal Phase 3 Trial of CardiAMP Cell Therapy for the Treatment of Ischemic Heart Failure

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies

BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes

Bayer to Present New Investigational Heart Failure Data, Continued Portfolio Research

Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP?HF II trial

Leaky Heart Valves

Dapagliflozin effects on exercise, cardiac remodeling, biomarkers, and renal and pulmonary function in heart failure patients: not as good as expected?

Stay Connected